Fundraising Fox

Nine Square Therapeutics

New York, US · Founded 2020 · Delaware corporation

Biotech

Founders & leadership

Board

SH
Seth HarrisonBoard director
SLSpiros Liras
Spiros Lirasin𝕏Board directorVenture Partner at Apple Tree Venture Management Llc
ME
Michael EhlersinBoard directorVenture Partner at Apple Tree Venture Management Llc
MJ
Matthew JacobsonBoard director

Reported raises · per SEC filings

Form D private placements

$4.2M disclosed across 1 round · 2020

▶$4.2MraisedFeb 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew JacobsonDirector
  • Seth HarrisonDirector
  • Spiros LirasExecutive Officer, Director
  • Michael EhlersDirector
Offering amount
$50M
Amount sold
$4.2M
First sale
Jun 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Nine Square Therapeutics Launches With $50M in Series A - FinSMEsfinsmes.com · Jul 2020Apple Tree Partners Founds Nine Square Therapeutics to Pioneer Novel Treatments for Movement Disordersfinance.yahoo.com · Jul 2020

Frequently asked questions

How much funding has Nine Square Therapeutics raised?
Nine Square Therapeutics has disclosed $4.2M raised across 1 round.
Where is Nine Square Therapeutics headquartered?
Nine Square Therapeutics is headquartered in New York, US.